AVE 0.00% 0.2¢ avecho biotechnology limited

marketing is the key to poh growth, page-24

  1. 379 Posts.
    Might the following be a fair summary?

    - POH's delivery system is self evidently perfectly well known in the pharma/scientific community. Evidence:- the number of projects currently in collaboration with, more importantly paid for by, various pharmas., including majors. In that connection, I noted from Dr.O's presentation (for which thanks to Oscar)that all projects other than OXY are currently being paid for by partners.
    - As far as Elixia/Cellulite is concerned, scientific/pharma exposure is irrelevant. 'Marketing' is about getting a product to the attention of the consumer - a product that on the face of it is indistinguishable from hundreds of other 'snake oils', as somebody very aptly put it. The question that divides many of us is whether tiny, cash strapped POH can possibly do that alone. I've posted (far too) often where I see that. Pray that cellulite reduction somehow is so good it gets picked up by a major & POH get an offer they can't refuse.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
0.000(0.00%)
Mkt cap ! $6.338M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
22 34784472 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 34738413 20
View Market Depth
Last trade - 16.12pm 14/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.